You might also like
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that develops and provides innovative medical devices for the treatment of underserved chronic diseases. The company focuses on improving patient outcomes and enhancing quality of life by delivering at-home healthcare solutions primarily in the United States. Tactile Medical sells products that address vascular diseases, oncology-related conditions, and chronic respiratory conditions.
-
Lymphedema Products - Develops and markets advanced pneumatic compression systems for the treatment of lymphedema, including the Flexitouch Plus, Entre Plus, and Nimbl, which are designed to improve patient care and outcomes.
- Flexitouch Plus - A third-generation system with multiple FDA 510(k) clearances for various indications.
- Entre Plus - A simpler compression pump for patients not yet qualifying for insurance reimbursement for advanced devices.
- Nimbl - A next-generation platform cleared for upper extremity lymphedema, with plans to expand to lower extremity lymphedema.
-
Airway Clearance Products - Offers the AffloVest, a portable, wearable vest that provides airway clearance therapy for patients with chronic respiratory conditions.
| Name | Position | External Roles | Short Bio | |
|---|---|---|---|---|
Sheri L. Dodd ExecutiveBoard | Chief Executive Officer (CEO) | None | Nearly 30 years of experience in global pharmaceutical, medical device, and digital health industries. Formerly President of Medtronic Canada and VP roles at Medtronic and Johnson & Johnson. | View Report → |
Elaine M. Birkemeyer Executive | Chief Financial Officer (CFO) | None | Over 26 years of experience in finance and strategy. Former CFO of Optum Care Solutions and Rally Health at UnitedHealth Group. Held senior roles at Best Buy Co., Inc. | |
Kristie T. Burns Executive | SVP, Marketing & Clinical Affairs | None | Extensive experience in marketing and product launches. Former Chief Marketing Officer at Cala Health, Inc. and VP of Solutions Marketing at ResMed Inc. | |
B. Vindell Washington Board | Director | Chief Clinical Officer for Care and Director of Health Equity Center of Excellence at Verily Life Sciences, LLC | Over 30 years of experience in healthcare, technology, and policy. Former National Coordinator for Healthcare IT at HHS and Chief Medical Officer at Blue Cross Blue Shield of Louisiana. | |
Carmen B. Volkart Board | Director | Board Member at Modular Medical, Inc. | Over 40 years of financial and managerial experience. Former CFO of NatureWorks, LLC, and led a $600M capital project financing. | |
Laura G. King Board | Director | Co-founder and CEO of BiaCure, Inc. | Former President and CEO of GE Healthcare\u2019s Global Interventional Business. Co-founder of Elucent Medical and NeuWave Medical, both focused on innovative healthcare solutions. | |
Raymond O. Huggenberger Board | Director | Board Member at Sommetrics and Avation Medical | Former CEO of Inogen, Inc. and President/COO of Sunrise Medical Inc. Extensive experience in medical device management and board service. | |
Valerie L. Asbury Board | Director | President and CEO of LifeScan, Inc. | Over 20 years of leadership experience in the diabetes medical device industry. Former Global President of Diabetes Solutions at Johnson & Johnson. | |
William W. Burke Board | Chairman of the Board | President of Austin Highlands Advisors, LLC; Board Member at Adtalem Global Education Inc. and Ceribell, Inc. | Extensive experience in corporate governance and financial oversight. Former CFO of publicly traded companies and board member of multiple organizations. |
-
With Q3 revenue results below expectations due to increased Medicare documentation requirements and uneven DME buying patterns in airway clearance, how confident are you that your mitigation strategies will effectively drive revenue growth in the coming quarters?
-
Given the retirement of the LCD and the sole reliance on the NCD, which still contains language ambiguities allowing MACs to interpret policies similarly to before, what risks do you foresee in claim adjudications, and how might this impact your future revenue projections?
-
Despite lowering your full-year revenue guidance, you've raised your adjusted EBITDA expectations; can you detail the specific factors contributing to your expanding margins and whether these improvements are sustainable long term?
-
Considering that the launch of Nimbl is expected to have minimal impact on Q4, how do you plan to leverage new product introductions like Nimbl to accelerate growth and offset challenges in your lymphedema business moving forward?
-
With increased documentation requirements impacting sales rep productivity across all channels and causing patient leakage, what specific steps are you taking to prevent further patient drop-offs and to enhance sales force effectiveness, particularly in regaining momentum with Medicare referrals?
Competitors mentioned in the company's latest 10K filing.
| Company | Description |
|---|---|
Bio Compression Systems, Inc. | This company is identified as one of the most significant manufacturing competitors in the pneumatic compression pump market. The market is expected to become increasingly competitive due to its growth. |
Lympha Press USA | This company is highlighted as a significant manufacturing competitor in the pneumatic compression pump market, which is anticipated to face heightened competition in the future. |
This competitor operates in the airway clearance market and manufactures HFCWO vests. The company is noted for its presence in a competitive market where portability and distribution strategies are key differentiators. | |
This company is a competitor in the airway clearance market, focusing on HFCWO vests. The market is described as vigorous and competitive, with opportunities for differentiation through product features and distribution. | |
Electromed | This competitor is active in the airway clearance market, producing HFCWO vests. The market is characterized by strong competition and the need for innovative product development. |
Medi | This company is listed as a competitor in the medical device industry, which is highly competitive and includes companies with established products and greater resources. |
Airos Medical, Inc. | This competitor is mentioned in the context of the medical device industry, which is marked by intense competition and rapid technological advancements. |
NormaTec Industries | This company is identified as a competitor in the medical device industry, which includes firms with significant name recognition and established distribution networks. |
Koya Medical | This competitor is noted in the medical device industry, which is described as highly competitive and subject to rapid changes and advancements. |
| Customer | Relationship | Segment | Details |
|---|---|---|---|
Veterans Administration | Sells or rents products directly, bills VA on behalf of patients | All | 11% of 2024 total revenue (~$32.23 million) ; 10% in 2023. |
Medicare | Company bills Medicare on behalf of patients | All | 18% of 2024 total revenue (~$52.74 million) ; 24% in 2023. |
Notable M&A activity and strategic investments in the past 3 years.
| Company | Year | Details |
|---|---|---|
AffloVest | 2021 | Acquisition Value & Structure: The deal was valued at up to $100 million, with $80 million paid at closing, $0.5 million placed in escrow for post-closing adjustments, and an additional $20 million contingent on future revenue performance over two 12‑month periods. The transaction was financed using cash and $55 million in borrowings under an existing credit facility. Strategic Rationale & Business Fit: This acquisition supports Tactile Medical’s strategy to expand its portfolio in treating underserved chronic respiratory conditions by adding the portable, wearable AffloVest device, which serves a market estimated at over $10 billion annually. Key Capabilities & Notable Terms: The acquired AffloVest business, with its high gross margins (over 70%) and strong adjusted EBITDA margins (above 30%), brings a specialized airway clearance solution for conditions like COPD, bronchiectasis, neuromuscular disorders, and cystic fibrosis, and includes the integration of an 11-member sales team. |
No recent press releases or 8-K filings found for TCMD.